or Try an Advanced Search...

    Solid Tumor Cancers Stocks List

    Symbol Grade Name % Change
    CRDF B Cardiff Oncology, Inc. 1.25
    IMCR D Immunocore Holdings plc 0.02
    NEO D NeoGenomics, Inc. 3.32
    INAB F IN8bio, Inc. -3.75
    MNOV F MediciNova, Inc. -0.76
    GNTA F Genenta Science S.p.A. 1.23
    CKPT F Checkpoint Therapeutics, Inc. -0.70
    NCNA F NuCana plc 0.92
    NVCR F NovoCure Limited 2.78
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Medical Instruments & Supplies
    Related Stock Lists: Cancer Medicine Clinical Medicine Oncology Biotechnology Solid Tumors Biology Brain Tumor Cancer Immunotherapy Chemotherapy Glioblastoma Leukemia Lymphoma Small Cell Lung Cancer Treatment Of Cancer Acute Leukemia Acute Myeloid Leukemia Adenosine Advanced Solid Tumors Aging Associated Diseases

    Related ETFs - A few ETFs which own one or more of the above listed Solid Tumor Cancers stocks.

    Symbol Grade Name Weight
    GERM F ETFMG Treatments Testing and Advancements ETF 3.35
    SBIO D ALPS Medical Breakthroughs ETF 1.94
    XHS C SPDR S&P Health Care Services ETF 1.83
    BBP D BioShares Biotechnology Products Fund 1.74
    PSCH D PowerShares S&P SmallCap Health Care Portfolio 1.55
    View all Solid Tumor Cancers ETFs...
    Compare ETFs
    Compare GERM to XHS Compare SBIO to PSCH Compare SBIO to XHS

        Solid Tumor Cancers Stocks Recent News

        Date Stock Title
        Apr 25 CRDF Cardiff Oncology to Report First Quarter 2024 Results and Provide Business Update
        Apr 25 NVCR NovoCure (NVCR) Expected to Beat Earnings Estimates: Should You Buy?
        Apr 24 NVCR Results of Novocure’s METIS Phase 3 Clinical Trial for Patients with Brain Metastasis from Non-Small Cell Lung Cancer to be Presented as Late-Breaking Abstract at ASCO 2024
        Apr 24 NEO Will Myriad Genetics (MYGN) Report Negative Q1 Earnings? What You Should Know
        Apr 24 IMCR Immunocore announces upcoming presentation and posters at ASCO 2024
        Apr 24 INAB IN8bio Announces Oral Presentation at the Upcoming American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
        Apr 23 NEO NeoGenomics (NEO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
        Apr 22 INAB INAB: Initiating Coverage – Enhancing the Insurgents of the Immune System
        Related Industries: Biotechnology Diagnostics & Research Medical Instruments & Supplies
        Related Stock Lists: Cancer Medicine Clinical Medicine Oncology Biotechnology Solid Tumors Biology Brain Tumor Cancer Immunotherapy Chemotherapy Glioblastoma Leukemia Lymphoma Small Cell Lung Cancer Treatment Of Cancer Acute Leukemia Acute Myeloid Leukemia Adenosine Advanced Solid Tumors Aging Associated Diseases
        Solid Tumor Cancers

        Solid tumor cancers are a type of cancer that forms in solid organs or tissues of the body. These tumors can be benign (non-cancerous) or malignant (cancerous). Solid tumor cancers can occur in any organ or tissue, including the brain, breast, colon, pancreas, and prostate. Treatment for solid tumor cancers typically involves surgery, chemotherapy, radiation, and/or targeted therapy.

        Browse All Tags